Alex Garland's 'Elden Ring' Movie At A24 Sets March 2028 Release

A24 and Bandai Namco Entertainment will release the film adaptation of Elden Ring on March 3, 2028, with Alex Garland set to write and direct and Kit Connor and Ben Whishaw starring. The project is currently in production and will be shot in Imax, with George R. R. Martin among the producers. The news is a positive development for the film and gaming IP franchises, but it is unlikely to have a major near-term market impact.

Analysis

IMAX is the cleanest listed beneficiary, but the market is likely underappreciating how film/IP adaptations can change the expected value of premium-format screens. A successful launch here is not just opening-weekend box office; it can extend into a multi-quarter re-rating of IMAX’s content pipeline if the studio uses the property as a tentpole and the fanbase drives repeat premium-format viewings. The second-order effect is leverage to a relatively fixed-cost network: incremental attendance from a culturally sticky franchise falls through at high margin, which matters more than raw admissions growth.

The real setup is less about the film itself and more about timing. A 2028 release gives a long-dated call on execution, and over that horizon the risk is that the project becomes “priced in” long before revenues hit, limiting near-term stock reaction unless IMAX management can stack additional franchise titles. Conversely, any production delay, casting churn, or visual-effects slippage would matter disproportionately because this is the kind of property where audience expectations are high and the premium-format thesis depends on event-level quality rather than broad awareness.

Consensus is probably too simplistic in assuming any major game adaptation is automatically bullish for exhibitors. The better read is that only a subset of IP with deep community engagement and strong visual identity actually converts into premium-screen demand, and this is one of them; that makes the upside real but more conditional than headline sentiment suggests. The contrarian risk is that the fanbase’s standards are extremely high, so a mediocre trailer or weak early reviews could invert the setup quickly and reduce IMAX’s share of the benefit even if box office is solid.

Key Decisions for Investors

• Long IMAX on any pre-release weakness over the next 3-6 months; use a staggered entry because the market may discount the title until marketing proof points appear. Risk/reward is attractive if the company can add even 1-2 more premium-format franchise dates alongside this release.
• Buy IMAX call spreads 6-12 months out if implied vol stays subdued; the convexity is best in a name where a single franchise event can lift sentiment, but paid options cap downside if the film underwhelms.
• Pair long IMAX / short a generic theater-exposed basket on strength, favoring the exhibitor with differentiated premium-format economics over peers with less pricing power. This is a cleaner expression of event-content scarcity than a broad media long.
• If the stock runs hard into formal production milestones, take partial profits and keep a smaller core position for 2027-2028 marketing catalysts; the trade is more about staged sentiment accrual than one-shot monetization.
• Avoid chasing the announcement reaction in the broader media complex; the move is likely to be concentrated in premium-format and franchise-content proxies rather than a durable uplift across all entertainment equities.